Kercheville Advisors, LLC Bristol Myers Squibb CO Transaction History

Kercheville Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $181,268 - $205,523	3,778 New	3,778 $204,000
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $153,234 - $171,340	-2,647 Reduced 22.06%	9,354 $542,000
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $23,254 - $25,820	-365 Reduced 2.95%	12,001 $767,000
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $123,534 - $140,116	-1,880 Reduced 13.2%	12,366 $857,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $273 - $324	4 Added 0.03%	14,246 $1.02 Million
Q3 2022 Oct 17, 2022	SELL	$0.13 - $76.84 $44 - $26,586	-346 Reduced 2.37%	14,242 $1.01 Million
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $761,057 - $838,190	-10,480 Reduced 41.81%	14,588 $1.12 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $632,444 - $758,357	10,287 Added 69.6%	25,068 $1.83 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $46,658 - $54,392	-870 Reduced 5.56%	14,781 $922,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $461,881 - $541,033	-7,806 Reduced 33.28%	15,651 $926,000
Q2 2021 Nov 15, 2021	BUY	$61.91 - $67.42 $15,972 - $17,394	258 Added 1.11%	23,457 $1.57 Million
Q1 2021 Nov 15, 2021	SELL	$59.34 - $66.74 $813,966 - $915,472	-13,717 Reduced 37.16%	23,199 $1.46 Million
Q4 2020 Nov 12, 2021	BUY	$57.74 - $65.43 $2.13 Million - $2.42 Million	36,916 New	36,916 $2.27 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.